SG11201507370TA - Multi-layered injectable self-assembling peptide scaffold hydrogels for long-term sustained release of human antibodies - Google Patents

Multi-layered injectable self-assembling peptide scaffold hydrogels for long-term sustained release of human antibodies

Info

Publication number
SG11201507370TA
SG11201507370TA SG11201507370TA SG11201507370TA SG11201507370TA SG 11201507370T A SG11201507370T A SG 11201507370TA SG 11201507370T A SG11201507370T A SG 11201507370TA SG 11201507370T A SG11201507370T A SG 11201507370TA SG 11201507370T A SG11201507370T A SG 11201507370TA
Authority
SG
Singapore
Prior art keywords
layered
long
sustained release
human antibodies
assembling peptide
Prior art date
Application number
SG11201507370TA
Other languages
English (en)
Inventor
Sotirios Koutsopoulos
Shuguang Zhang
Original Assignee
Massachusetts Inst Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Inst Technology filed Critical Massachusetts Inst Technology
Publication of SG11201507370TA publication Critical patent/SG11201507370TA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Anesthesiology (AREA)
SG11201507370TA 2013-03-14 2014-03-14 Multi-layered injectable self-assembling peptide scaffold hydrogels for long-term sustained release of human antibodies SG11201507370TA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361782791P 2013-03-14 2013-03-14
PCT/US2014/027693 WO2014152751A1 (en) 2013-03-14 2014-03-14 Multi-layered injectable self-assembling peptide scaffold hydrogels for long-term sustained release of human antibodies

Publications (1)

Publication Number Publication Date
SG11201507370TA true SG11201507370TA (en) 2015-10-29

Family

ID=51581306

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201507370TA SG11201507370TA (en) 2013-03-14 2014-03-14 Multi-layered injectable self-assembling peptide scaffold hydrogels for long-term sustained release of human antibodies

Country Status (7)

Country Link
US (1) US9700521B2 (enExample)
EP (1) EP2968135A4 (enExample)
JP (1) JP6134050B2 (enExample)
CN (1) CN105228592A (enExample)
HK (2) HK1218858A1 (enExample)
SG (1) SG11201507370TA (enExample)
WO (1) WO2014152751A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010033726A2 (en) 2008-09-17 2010-03-25 The Brigham And Women's Hospital, Inc. Drug delivery composition comprising a self-assembled gelator
WO2012040623A2 (en) 2010-09-24 2012-03-29 The Brigham And Women's Hospital, Inc. Nanostructured gels capable of controlled release of encapsulated agents
PL3219330T3 (pl) * 2014-11-14 2020-07-13 3-D Matrix, Ltd. Synteza nano-agregatu chitozanu modyfikowanego przez samoorganizujący się peptyd i jego zastosowanie do dostarczania białka
WO2016138525A1 (en) 2015-02-27 2016-09-01 University Of Washington Polypeptide assemblies and methods for the production thereof
EP3322714B1 (en) * 2015-07-13 2020-09-30 Universiteit Gent Hydrogel-forming peptides
ES2981890T3 (es) 2015-07-24 2024-10-11 Trimph Ip Pty Ltd Polímero antiséptico y síntesis del mismo
US10449259B2 (en) 2015-10-02 2019-10-22 Cornell University Enzyme-responsive peptide nanofiber compositions and uses thereof
CN108289833B (zh) 2015-10-08 2022-01-25 布里格姆及妇女医院股份有限公司 用于递送囊封剂的稳定的已组装纳米结构
WO2017140792A1 (en) 2016-02-16 2017-08-24 Vrije Universiteit Brussel Hydrogel-forming composition for controlled released
EP3978022A1 (en) 2016-05-06 2022-04-06 The Brigham and Women's Hospital, Inc. Binary self assembled gels for controlled delivery of encapsulated agents to cartilage
CA3062885C (en) * 2016-05-06 2022-03-29 The Brigham And Women's Hospital, Inc. Self-assembled gels for controlled delivery of biologics and labile agents
WO2018144991A1 (en) 2017-02-03 2018-08-09 The Brigham And Women's Hospital, Inc. Self-assembled gels formed with anti-retroviral drugs, prodrugs thereof, and pharmaceutical uses thereof
AU2018266131B2 (en) 2017-05-08 2021-07-29 Alivio Therapeutics, Inc. Formulation of nanostructured gels for increased agent loading and adhesion
US11661439B2 (en) 2017-12-17 2023-05-30 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Peptide hydrogels and use thereof
US20190307885A1 (en) * 2018-04-04 2019-10-10 Alivio Therapeutics, Inc. Self-assembled gels for controlled delivery of biologics and methods of making thereof
CA3113948A1 (en) 2018-10-11 2020-04-16 Alivio Therapeutics, Inc. Non-injectable hydrogel formulations for smart release
EP4004016A4 (en) * 2019-07-22 2023-07-26 Agency for Science, Technology and Research A series of injectable hydrogels self-assembled from short peptides for various biomedical applications
US12037418B2 (en) * 2020-06-30 2024-07-16 Nanyang Technological University Hydrogel-forming peptides, and methods of use thereof
CN111939323B (zh) * 2020-08-08 2022-06-10 武汉速普生物科技有限公司 含有透明质酸连接肽和连接蛋白末端肽的功能性多肽水凝胶及其应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5955343A (en) 1992-12-28 1999-09-21 Massachusetts Institute Of Technology Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
US5670483A (en) 1992-12-28 1997-09-23 Massachusetts Insititute Of Technology Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
US7449180B2 (en) 2001-02-06 2008-11-11 John Kisiday Macroscopic scaffold containing amphiphilic peptides encapsulating cells
US7179784B2 (en) 2001-07-10 2007-02-20 Massachusetts Institute Of Technology Surfactant peptide nanostructures, and uses thereof
US7943575B2 (en) * 2002-03-04 2011-05-17 Ipsen Pharma S.A.S. Sustained release drug formulations containing a carrier peptide
AU2003249606A1 (en) 2002-05-13 2003-12-02 Massachusetts Institute Of Technology Angiogenesis and cardiac tissue engineering with peptide hydrogels and related compositions and methods of use thereof
US7713923B2 (en) 2003-06-25 2010-05-11 Massachusetts Institute Of Technology Self-assembling peptides incorporating modifications and methods of use thereof
US7846891B2 (en) 2003-10-17 2010-12-07 Massachusetts Institute Of Technology Self-assembling peptides for regeneration and repair of neural tissue
US8039258B2 (en) * 2004-09-28 2011-10-18 Ethicon, Inc. Tissue-engineering scaffolds containing self-assembled-peptide hydrogels
WO2006116524A1 (en) 2005-04-25 2006-11-02 Massachusetts Institute Of Technology Compositions and methods for promoting hemostasis and other physiological activities
WO2008039483A2 (en) 2006-09-26 2008-04-03 Massachusetts Institute Of Technology Modified self-assembling peptides
US20090069547A1 (en) 2007-05-01 2009-03-12 Massachusetts Institute Of Technology Stabilization of mammalian membrane proteins by short surfactant peptides
US8729032B2 (en) 2009-03-09 2014-05-20 Menicon Co., Ltd. Self-assembling peptide and peptide gel with high strength
US20110200560A1 (en) 2009-05-26 2011-08-18 Massachusetts Institute Of Technology Non-ionic self-assembling peptides and uses thereof
JP5732691B2 (ja) 2010-01-14 2015-06-10 学校法人同志社 インスリン製剤
US8741833B2 (en) 2010-07-16 2014-06-03 Massachusetts Institute Of Technology Self-assembling peptides incorporating modifications and methods of use thereof
CN108752461A (zh) 2011-02-23 2018-11-06 麻省理工学院 水溶性膜蛋白及其制备和使用方法
CN102526753B (zh) * 2011-12-15 2014-01-22 成都师创生物医药科技有限公司 一种以磷脂为基质的原位相变凝胶缓释系统及其制备方法
CA2874003A1 (en) 2012-05-31 2013-12-05 Sotirios KOUTSOPOULOS Sustained delivery of molecules using peptide surfactants and uses thereof
US20150370960A1 (en) 2014-03-27 2015-12-24 Massachusetts Institute Of Technology Water-soluble membrane proteins and methods for the preparation and use thereof
US10373702B2 (en) 2014-03-27 2019-08-06 Massachusetts Institute Of Technology Water-soluble trans-membrane proteins and methods for the preparation and use thereof

Also Published As

Publication number Publication date
WO2014152751A1 (en) 2014-09-25
JP2016515136A (ja) 2016-05-26
JP6134050B2 (ja) 2017-05-24
EP2968135A1 (en) 2016-01-20
US20140302144A1 (en) 2014-10-09
HK1218858A1 (zh) 2017-03-17
CN105228592A (zh) 2016-01-06
EP2968135A4 (en) 2016-10-26
US9700521B2 (en) 2017-07-11
HK1220401A1 (zh) 2017-05-05

Similar Documents

Publication Publication Date Title
SG11201507370TA (en) Multi-layered injectable self-assembling peptide scaffold hydrogels for long-term sustained release of human antibodies
IL283012A (en) Sustained release formulations of linclotide
CL2016000157A1 (es) Bioconjugados de polipétidos de apelina sintética
SG11201506876XA (en) Modification of polypeptides
IL240286A0 (en) Genetic modification of rats
SG11201600734YA (en) Stabilization of fc-containing polypeptides
PT3030262T (pt) Composição farmacêutica de associação
EP2940135A4 (en) HETERODIMIZED POLYPEPTIDE
LT2986722T (lt) Rekombinantiniai fenilalanino amonio liazės polipeptidai
DK3071593T3 (da) Modificerede humane t-celle-receptorer med høj affinitet
IL272828A (en) Growth hormone receptor modulators
LT2968477T (lt) Faktoriaus viii polipeptido kompozicijos
IL286537A (en) Synthetic proteins that assemble themselves
IL241418A0 (en) Improved methods of use for recombinant human secretoglobins
IL241434A0 (en) Therapeutic uses for 1vegfr antibodies
IL243027A0 (en) A pharmaceutical preparation for delayed release of lanureotide
PL2991618T3 (pl) Stabilna kompozycja farmaceutyczna o wysokim stężeniu lewoleukoworyny
EP2973500A4 (en) MOVEMENT PLATFORM CONFIGURATION
SG11201508621PA (en) HIGHLY CONCENTRATED FORMULATIONS OF SOLUBLE Fc RECEPTORS
GB201319445D0 (en) Self-assembly of nanotubes
IL243730B (en) Vasopressin-2 receptor agonist peptides
SG11201505941PA (en) Cytoplasmic expression of fab proteins
EP2978770A4 (en) REINFORCEMENT OF PROTEINS
DK2763647T3 (da) Klæbepræparat til kæbeproteser
GB201321911D0 (en) N-Glycosylation of peptides and proteins